您要查找的是不是：
- Glycogen storage myopathy 糖原沉积性肌病
- Objective To study 20 cases of lipid storage myopathy (LSM) and to analyze them in clinical and pathological fields. 目的从临床和肌肉病理的角度分析脂质沉积性肌病(LSM)的特点。
- Objective:To investigate the clinical and pathological features of Lipid storage myopathy(LSM). 目的:探讨脂质沉积性肌病(LSM)的临床和肌肉病理特点。
- Objective To study the clinical, neuro-electrophysiological and pathological features of lipid storage myopathy (LSM). 摘要目的研究脂质沉积性肌病(LSM)的临床、神经电生理及病理学特点。
- Other functions of the liver include glycogen storage, red blood cells decomposition and some protein synthesis. 肝脏的其他功能包括贮存肝糖、分解红血球和一些蛋白质的合成。
- Objective:To analyze the clinical characteristic of pediatric glycogen storage disease. 目的:分析儿童期肝糖原累积病的临床特点。
- Objective To analyze the clinical and pathological features of lipid storage myopathy (LSM) caused by primary carnitine deficiency (CD). 摘要目的分析原发性肉碱缺乏致脂质沉积性肌病(LSM)的临床与病理特点。
- Increase glycogen storage when combined with carbohydrate; increase protein synthesis, protect the immune system, evidence is strong. 当结合糖类时增加糖原的储存,增强蛋白质合成,保护免疫系统,证据充分的。
- Acid maltase deficiency (AMD) is a form of glycogen storage disease, which is an inherited autosomal recessive disease and rarely found in adults. 摘要酸性麦芽糖酵素缺乏症在成人当中是一个罕见的遗传染色体隐性疾病。
- Methods: 42 children who were diagnosed as liver glycogen storage disease during January 1990 January 2006 were retrospectively analyzed. 方法：回顾分析1990年1月－2006年1月收治的42例以肝脏损害为主的肝糖原累积病患儿的临床资料。
- Lier transplantation (LT) may be indicated in glycogen storage disorders (GSD) when medical treatment fails to control the metabolic problems or when hepatic adenomas deelop. 当糖原累积病经药物治疗难以控制代谢问题或出现肝腺瘤时是行肝移植的指征。
- The mice were fed with Compound Huangqi extract for 30 days to observe the time of burden swimming,glycogen storage,blood lactate and blood urea after exercising. 经口给予小鼠不同剂量的复方黄芪提取液30天,观察小鼠的负重游泳时间、肝糖原储备量以及运动后血乳酸和血尿素的变化;实验结果表明复方黄芪提取液具有抗运动性疲劳的作用。
- Type I Glycogen Storage Disease accounts for about 25% of all cases of GSD diagnosed in the USA and in Europe and has an estimated incidence of about 1 in 100,000 live births. 第一类型肝糖储藏疾病占有在美国和欧洲被诊断而且有 100,000 的活的出生的大约 1 被估计的影响之方式的 GSD 的大约 25%25 的所有情形。
- From our experiment, the health care product B increases the storage of both liver and muscle glycogen, and also either increasing of glycogen storage or reduction of glycogen consumption. 本实验结果表明，保健品B能使疲劳小鼠的肝糖元及肌糖元含量均明显增加，提示其有促进糖原储备或减少糖原消耗的作用。
- Mitochondrial-lipid-glycogen storage myopathy 线粒体-脂质-糖原贮积肌病
- Debrancher deficiency glycogen storage disease 脱支链缺乏糖原贮积病
- cerebral glycogen storage disease 大脑性糖原贮积病
- hepatic glycogen storage disease 肝糖原贮积病
- hepatorenal glycogen storage disease 肝肾糖原贮积病:即糖原贮积病Ⅵ型
- Brancher deficiency glycogen storage disease 分支酶缺乏性糖原贮积病GSD
